10-110812414-C-T
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_001134363.3(RBM20):c.2017C>T(p.Arg673Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000599 in 1,551,546 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R673Q) has been classified as Likely benign.
Frequency
Consequence
NM_001134363.3 missense
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- dilated cardiomyopathy 1DDInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RBM20 | NM_001134363.3 | c.2017C>T | p.Arg673Trp | missense_variant | Exon 9 of 14 | ENST00000369519.4 | NP_001127835.2 | |
| RBM20 | XM_017016103.3 | c.1852C>T | p.Arg618Trp | missense_variant | Exon 9 of 14 | XP_016871592.1 | ||
| RBM20 | XM_017016104.3 | c.1633C>T | p.Arg545Trp | missense_variant | Exon 9 of 14 | XP_016871593.1 | ||
| RBM20 | XM_047425116.1 | c.1633C>T | p.Arg545Trp | missense_variant | Exon 9 of 14 | XP_047281072.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152168Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000451 AC: 7AN: 155232 AF XY: 0.0000728 show subpopulations
GnomAD4 exome AF: 0.0000615 AC: 86AN: 1399378Hom.: 0 Cov.: 32 AF XY: 0.0000724 AC XY: 50AN XY: 690198 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74350 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
The R673W variant in the RBM20 gene was reported in an individual referred for DCM genetic testing with a family history of sudden death; however, this individual also harbored a second variant of unknown significance in the RBM20 gene (R1008W) as well as a TTN intronic variant (Pugh et. al., 2014). The study did not provide other clinical or family history information. Additionally, The R673W variant was not observed in approximately 2,200 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R673W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. However, missense mutations in nearby residues have not been reported, indicating this region of the protein my tolerate change. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. -
- -
not specified Uncertain:1Benign:1
Variant classified as Uncertain Significance - Favor Pathogenic. The Arg673Trp v ariant in RBM20 has been identified by our laboratory in one adult with DCM. Dat a from large population studies is insufficient to assess the frequency of this variant. Computational prediction tools and conservation analysis suggest that t his variant may impact the protein, though this information is not predictive en ough to determine pathogenicity. Pathogenic RBM20 variants frequently occur in e xon 9 of RBM20 (Brauch 2009, Li 2010), where this variant is located, though it is unclear why certain variants in this exon have a strong association with dise ase. In summary, while there is some suspicion for a pathogenic role, the clinic al significance of the Arg673Trp variant is uncertain. -
- -
Cardiovascular phenotype Uncertain:1
The c.2017C>T (p.R673W) alteration is located in exon 9 (coding exon 9) of the RBM20 gene. This alteration results from a C to T substitution at nucleotide position 2017, causing the arginine (R) at amino acid position 673 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Dilated cardiomyopathy 1DD Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at